CD274 and melanoma: Fibroblast activation protein (FAP)-targeted PET imaging, as well as programmed death ligand-1 (PD-L1)-targeted PET imaging, have recently been shown to be extremely effective in the detection of various malignant cancers, including malignant melanoma.